Evaluation of a hepatitis C virus (HCV) antigen assay for routine HCV screening among men who have sex with men infected with HIV

Journal of Virological Methods

Volumn 213, Issue , 2015, Pages 147-150

  Vanhommerig, Joost W ^a,b   van de Laar, Thijs J W ^c   Koot, Maarten ^c   van Rooijen, Martijn S ^a   Schinkel, Janke ^b   Speksnijder, Arjen G C L ^a   Prins, Maria ^a,b   de Vries, Henry J ^a,b   Bruisten, Sylvia M ^a  

^a DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

Author keywords

Acute HCV infection; HCV core antigen; Hepatitis C Virus; HIV coinfection; Men who have sex with men

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS C VIRUS ANTIGEN ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; IMMUNOREACTIVITY; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; NONHUMAN; SAMPLE SIZE; SCREENING; SENSITIVITY AND SPECIFICITY; BLOOD; COMPLICATION; CROSS-SECTIONAL STUDY; DIAGNOSTIC PROCEDURE; EVALUATION STUDY; HEPACIVIRUS; ISOLATION AND PURIFICATION; MALE HOMOSEXUALITY; MASS SCREENING; NETHERLANDS; PROCEDURES;

HEPATITIS C VIRUS;

CLINICAL LABORATORY TECHNIQUES; CROSS-SECTIONAL STUDIES; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; IMMUNOASSAY; MALE; MASS SCREENING; NETHERLANDS; SENSITIVITY AND SPECIFICITY;

EID: 84919897852     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2014.11.026     Document Type: Article

References (24)

1. Fierer D.S., Factor S.H., Uriel A.J., Carriero D.T., Dieterich M.P., Mullen A., Klepper, van Seggelen W., Childs K., Branch A.D., Holtzman D., Ward J.W., Khudyakov Y., Holmberg S.D. Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men - New York City, 2005-2010. Morb. Mortal. Wkly. Rep. 2011, 60:945-950.
2. Garbuglia A.R., Monachetti A., Galli C., Sabatini R., Ferreri M.L., Capobianchi M.R., Bagnarelli P. HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes. BMC Infect. Dis. 2014, 14:222.
3. Gilleece Y.C., Browne R.E., Asboe D., Atkins M., Mandalia S., Bower M., Gazzard B.G., Nelson M.R. Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin. J. Acquir. Immune Defic. Syndr. 2005, 40:41-46.
4. Glynn S.A., Wright D.J., Kleinman S.H., Hirschkorn D., Tu Y., Heldebrant C., Smith R., Giachetti C., Gallarda J., Busch M.P. Dynamics of viremia in early hepatitis C virus infection. Transfusion 2005, 45:994-1002.
5. Hosseini-Moghaddam S.M., Iran-Pour E., Rotstein C., Husain S., Lilly L., Renner E., Mazzulli T. Hepatitis C core Ag and its clinical applicability: potential advantages and disadvantages for diagnosis and follow-up?. Rev. Med. Virol. 2012, 22:156-165.
6. Lambers F.A.E., Prins M., Thomas X.V., Molenkamp R., Kwa D., Brinkman K., van der Meer J.T.M., Schinkel J. Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM. AIDS 2011, 25:F21-F27.
7. Martin T.C., Martin N.K., Hickman M., Vickerman P., Page E.E., Everett R., Gazzard B.G., Nelson M. HCV reinfection incidence and treatment outcome among HIV-positive MSM in London. AIDS 2013, 27:2551-2557.
8. McLauchlan J. Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J. Viral Hepat. 2000, 7:2-14.
9. Mederacke I., Potthoff A., Meyer-Olson D., Meier M., Raupach R., Manns M.P., Wedemeyer H., Tillmann H.L. HCV core antigen testing in HIV- and HBV-coinfected patients, and in HCV-infected patients on hemodialysis. J. Clin. Virol. 2012, 53:110-115.
10. Mederacke I., Wedemeyer H., Ciesek S., Steinmann E., Raupach R., Wursthorn K., Manns M.P., Tillmann H.L. Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay. J. Clin. Virol. 2009, 46:210-215.
11. Murphy D.G., Willems B., Deschenes M., Hilzenrat N., Mousseau R., Sabbah S. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5' untranslated region sequences. J. Clin. Microbiol. 2007, 45:1102-1112.
12. Netski D.M., Mosbruger T., Depla E., Maertens G., Ray S.C., Hamilton R.G., Roundtree S., Thomas D.L., McKeating J., Cox A. Humoral immune response in acute hepatitis C virus infection. Clin. Infect. Dis. 2005, 41:667-675.
13. Ottiger C., Gygli N., Huber A.R. Detection limit of architect hepatitis C core antigen assay in correlation with HCV RNA, and renewed confirmation algorithm for reactive anti-HCV samples. J. Clin. Virol. 2013, 58:535-540.
14. Park Y., Lee J.H., Kim B.S., Kim D.Y., Han K.H., Kim H.S. New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification. J. Clin. Microbiol. 2010, 48:2253-2256.
15. Ross R.S., Viazov S., Salloum S., Hilgard P., Gerken G., Roggendorf M. Analytical performance characteristics and clinical utility of a novel assay for total hepatitis C virus core antigen quantification. J. Clin. Microbiol. 2010, 48:1161-1168.
16. Sulkowski M.S. Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors. Clin. Infect. Dis. 2004, 38:S90-S97.
17. Thomson E.C., Nastouli E., Main J., Karayiannis P., Eliahoo J., Muir D., McClure M.O. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS 2009, 23:89-93.
18. Urbanus A.T., van de Laar T.J., Stolte I.G., Schinkel J., Heijman T., Coutinho R.A., Prins M. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS 2009, 23:F1-F7.
19. Urbanus, Van De Laar T.J.W., Geskus R., Vanhommerig J.W., Van Rooijen M.S., Schinkel J., Heijman T., Coutinho R.A., Prins M. Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995-2010. AIDS 2014, 28:781-790.
20. Van de Laar T.J.W., van der Bij A.K., Prins M., Bruisten S.M., Brinkman K., Ruys T.A., van der Meer J.T., de Vries H.J., Mulder J.W., van Agtmael A.M., Jurriaans S., Wolthers K.C., Coutinho R.A. Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J. Infect. Dis. 2007, 196:230-238.
21. Van der Helm J.J., Prins M., del Amo J., Bucher H.C., Chene G., Dorrucci M., Gill J., Hamouda O., Sannes M., Porter K., Geskus R.B. The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007. AIDS 2011, 25:1083-1091.
22. Vanhommerig J.W., Thomas X.V., van der Meer J.T.M., Geskus R.B., Bruisten S.M., Molenkamp R., Schinkel J. Hepatitis C virus (HCV) antibody dynamics following acute HCV infection and reinfection among HIV-infected men who have sex with men. Clin. Infect. Dis. 2014, 59:1678-1685.
23. Vermehren J., Susser S., Berger A., Perner D., Peiffer K.H., Allwinn R., Zeuzem S., Sarrazin C. Clinical utility of the ARCHITECT HCV Ag assay for early treatment monitoring in patients with chronic hepatitis C genotype 1 infection. J. Clin. Virol. 2012, 55:17-22.
24. Vogel M., Deterding K., Wiegand J., Gruner N.H., Baumgarten A., Jung M.C., Manns M.P., Wedemeyer H., Rockstroh J.K. Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infection. Clin. Infect. Dis. 2009, 49:317-319.